Xiaoming Jin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glen Rock, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery...

IU researchers developing noninvasive brain stimulation technique to treat neurological disorders Indiana University School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury (TBI), epilepsy, Parkinson's disease, Alzheimer's disease and more. Given the increasing use of brain stimulation in human brain study and treatment of neurological diseases, this research can make a big impact on physicians and their patients." Xiaoming Jin, PhD, associate professor of anatomy, cell biology and ph...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs RespireRX Pharmaceuticals Inc.April 22, 2021 GMT Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to provide an update on its therapeutic drug development programs. EndeavourRx Scie...